Cancer charity chooses MK for new HQ

News
News
0
Have your say

National charity Brain Tumour Research has chosen Milton Keynes as the location for its new headquarters.

The move has been enabled by a period of unprecedented growth during which the charity has driven up national awareness of brain tumours and raised millions of pounds to fund research.

Brain Tumour Research, the UK’s only national brain tumour charity committed to investing all available funds in research, has relocated from offices in Padbury, near Buckingham, to Shenley Pavilions, Shenley Wood.

The charity was launched in 2009 by Sue Farrington Smith, who lost her sister’s little girl Alison Phelan just three weeks before her eighth birthday.

Sue was originally assisted by just one part-time member of staff. The organisation now employs 20 and aims to recruit a further eight over the coming months in order to fulfil supporter requirements and increase the amount invested in research and find a cure for this devastating disease.

The charity is supported by a large base of volunteers across the UK, many of whom have been affected in some way by a brain tumour diagnosis.

Chief Executive Sue Farrington Smith said: “With thousands of growing local firms and one of the highest start-up rates in the country, it is clear why many people consider Milton Keynes to be the UK’s most successful business city and we are delighted to become a part of this vibrant landscape.

“We look forward to getting to know the people who are putting the city on the map and we hope as many as possible will help us to help the 16,000 people who are diagnosed with a brain tumour each year.

“Brain tumours kill more children and adults under 40 than any other cancer yet just 1% of the national spend on cancer research has been allocated to this devastating disease.

“We think this is unacceptable and that is why we are striving to fund a network of seven dedicated research centres whilst challenging the government and larger cancer charities to invest more in brain tumour research.”